Erectile Dysfunction Drug Linked to Increased Glaucoma Risk, Experts Warn

Emily Watson, Health Editor
5 Min Read
⏱️ 3 min read

Recent research has raised concerns about the long-term use of tadalafil, a medication commonly prescribed for erectile dysfunction. Scientists suggest that men taking this drug may face a significantly heightened risk of developing glaucoma, a serious eye condition that can lead to blindness. This warning emphasises the need for regular eye health assessments for those using tadalafil, particularly for individuals with existing eye health issues.

Tadalafil and Eye Health

Tadalafil, also known for its effectiveness in addressing symptoms of an enlarged prostate, functions by relaxing muscles and enhancing blood flow. However, alongside its benefits, the medication is associated with potential risks to eye health, particularly those affecting the optic nerve and the macula—the critical area of the retina responsible for sharp vision. Researchers from Taiwan have found evidence indicating that long-term use of tadalafil may elevate the risk of glaucoma, a condition that currently affects over a million people in the UK alone, making it a leading cause of blindness worldwide.

The study, published in the esteemed *British Journal of Ophthalmology*, involved an extensive analysis of data from 73,854 men aged 40 and above who had previously reported lower urinary tract symptoms. Among these participants, half were prescribed tadalafil or another PDE5 inhibitor for a duration of up to five years, while the other half were treated with alternative medications.

Key Findings of the Study

The researchers meticulously paired subjects based on various lifestyle factors, such as ethnicity, smoking habits, and underlying health conditions including diabetes and obesity. Their objective was to compare the likelihood of developing glaucoma between the two groups after five years.

The findings revealed that men using tadalafil were 22% more prone to developing glaucoma and had a 32% increased likelihood of experiencing ocular hypertension. Furthermore, they were found to be 33% more likely to develop primary open-angle glaucoma, the most prevalent form of the disease. However, it is crucial to understand that this observational study does not establish a direct cause-and-effect relationship but rather highlights a correlation that warrants further investigation.

Understanding Glaucoma Symptoms

Glaucoma often progresses silently, frequently remaining undetected until a routine eye examination reveals its presence. The condition typically affects both eyes, although symptoms may be more pronounced in one. In rare cases, glaucoma can present suddenly, leading to severe symptoms such as intense eye pain, redness, sensitivity around the eyes, blurred vision, and rainbow-coloured halos around bright lights, alongside nausea, vomiting, and headaches.

Due to the insidious nature of glaucoma, which develops gradually over time, regular eye check-ups are vital for early detection and management. The NHS recommends that anyone with concerns about their vision consult their GP or an optician promptly.

The Importance of Monitoring Eye Health

While the researchers caution that their findings do not contraindicate the use of tadalafil, they strongly advocate for monitoring eye health among users. This is especially critical for individuals with a family history of glaucoma or pre-existing conditions that might increase their risk. Regular eye examinations can catch potential issues early, allowing for timely intervention that could prevent vision loss.

Why it Matters

The implications of this research are profound, as it underscores the necessity for vigilance in eye health among men using tadalafil. With rising rates of both erectile dysfunction and glaucoma, healthcare professionals must remain alert to the potential consequences of long-term medication use. This study serves as a clarion call for men to engage in open dialogue with their healthcare providers about their eye health, ensuring that proactive measures are taken to safeguard their vision while managing other health concerns.

Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy